Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Santamaria
Angelo Santamaria, Kernen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110089359 | SPRING RETAINING SLEEVE - The invention relates to a spring retaining sleeve having a cylinder press-fit connection surface which has a press-fit diameter and a press-fit length. To enable cost-effective production of a stable press-fit assembly, at least one end of the cylinder press-fit connection surface, an optimized insertion chamfer for long press-fit assemblies is provided with a ratio of press-fit diameter to press-fit length of greater than thirty five percent. | 04-21-2011 |
Angelo Santamaria, Esslingen DE
| Patent application number | Description | Published |
|---|---|---|
| 20080279707 | High-Pressure Pump, in Particular for a Fuel Injection Apparatus of an Internal Combustion Engine - The high-pressure pump has at least one pump element which has a pump plunger which is driven in a reciprocating motion and defines a pump working space into which fuel is drawn in from a fuel feed via an inlet valve during the suction stroke of the pump plunger and from which fuel is displaced into a high-pressure region via an outlet valve during the delivery stroke of the pump plunger. The inlet valve and/or the outlet valve has a valve member at least approximately in the shape of a ball which interacts by means of a sealing surface with a valve seat arranged in a valve housing. By means of the valve member, in the open state, when said valve member is lifted with its sealing surface from the valve seat, a first cross section of flow is cleared between the valve member and the valve seat, and downstream of the first cross section of flow, a second cross section of flow is formed between the valve member and the valve housing. In the direction of flow between the first cross section of flow and the second cross section of flow, a third cross section of flow is formed between the valve member and the valve housing, said third cross section of flow being larger than the first cross section of flow and the second cross section of flow. | 11-13-2008 |
Germán Solis Santamaria, Puebla MX
| Patent application number | Description | Published |
|---|---|---|
| 20100094035 | AMORPHOUS ADSORBENT, METHOD OF OBTAINING THE SAME AND ITS USE IN THE BLEACHING OF FATS AND/OR OILS - The invention relates to a method for producing an adsorbent, in particular a bleaching earth, wherein a clay material having: a surface area of 180 to 300 m2/g; a total pore volume of 0.5 to 0.7 ml/l; wherein at least 60% of the total pore volume are provided by pores having a pore diameter of at least 140 A, at least 40% of the total pore volume is provided by pores having a pore diameter of less than 250 A and at least 15% of the total pore volume are provided by pores having a pore diameter of 140 to 250 A; and said clay material having an amorphous structure according to XRD data; is activated by an activation procedure. Further, the invention relates to an adsorbent as obtained by the method and a method for purification of oils, fats and biofuels. | 04-15-2010 |
Germán Solis Santamaria, Puebla MX
| Patent application number | Description | Published |
|---|---|---|
| 20100094035 | AMORPHOUS ADSORBENT, METHOD OF OBTAINING THE SAME AND ITS USE IN THE BLEACHING OF FATS AND/OR OILS - The invention relates to a method for producing an adsorbent, in particular a bleaching earth, wherein a clay material having: a surface area of 180 to 300 m2/g; a total pore volume of 0.5 to 0.7 ml/l; wherein at least 60% of the total pore volume are provided by pores having a pore diameter of at least 140 A, at least 40% of the total pore volume is provided by pores having a pore diameter of less than 250 A and at least 15% of the total pore volume are provided by pores having a pore diameter of 140 to 250 A; and said clay material having an amorphous structure according to XRD data; is activated by an activation procedure. Further, the invention relates to an adsorbent as obtained by the method and a method for purification of oils, fats and biofuels. | 04-15-2010 |
Julie Santamaria, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100100978 | RNAi MEDIATED EXPRESSION INHIBITION OF A CHOLINERGIC PROTEIN - The present invention relates to nucleic acid sequences producing at least one functional miRNA, at least one functional shRNA and/or at least one functional siRNA, said miRNA, shRNA or siRNA being designed to silence the expression of a gene that encodes a cholinergic protein. The present invention further relates to compositions and kits comprising such nucleic acid sequences as well as to uses thereof. | 04-22-2010 |
Manuel Jane Santamaria, Palau Solita I Plegamans (barcelona) ES
| Patent application number | Description | Published |
|---|---|---|
| 20090139805 | BRAKE DEVICE FOR PRAMS - This device is actuated by a single control ( | 06-04-2009 |
Pedro Santamaria, Calgary CA
| Patent application number | Description | Published |
|---|---|---|
| 20090155292 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS - The methods include selectively reducing or expanding T cells according to the antigenic specificity of the T cells. Therefore, the present invention can be used to reduce or eliminate pathogenic T cells that recognize autoantigens, such as beta cell specific T cells. As such, the present invention can be used to prevent, treat or ameliorate autoimmune diseases such as IDDM. Furthermore, the present invention can be used to expand desirable T cells, such as anti-pathogenic T cells to prevent, treat and/or ameliorate autoimmune diseases. | 06-18-2009 |
| 20110059121 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS - The methods include selectively reducing or expanding T cells according to the antigenic specificity of the T cells. Therefore, the present invention can be used to reduce or eliminate pathogenic T cells that recognize autoantigens, such as beta cell specific T cells. As such, the present invention can be used to prevent, treat or ameliorate autoimmune diseases such as IDDM. Furthermore, the present invention can be used to expand desirable T cells, such as anti-pathogenic T cells to prevent, treat and/or ameliorate autoimmune diseases. | 03-10-2011 |